The genetic epidemiology of substance use disorder: A review.
- Authors
- Prom-Wormley, Elizabeth C; Ebejer, Jane; Dick, Danielle M; Bowers, M Scott
- Year
- 2017
- Journal
- Drug and alcohol dependence
- PMID
- 28938182
- DOI
- 10.1016/j.drugalcdep.2017.06.040
- PMCID
- PMC5911369
BACKGROUND: Substance use disorder (SUD) remains a significant public health issue. A greater understanding of how genes and environment interact to regulate phenotypes comprising SUD will facilitate directed treatments and prevention. METHODS: The literature studying the neurobiological correlates of SUD with a focus on the genetic and environmental influences underlying these mechanisms was reviewed. Results from twin/family, human genetic association, gene-environment interaction, epigenetic literature, phenome-wide association studies are summarized for alcohol, nicotine, cannabinoids, cocaine, and opioids. RESULTS: There are substantial genetic influences on SUD that are expected to influence multiple neurotransmission pathways, and these influences are particularly important within the dopaminergic system. Genetic influences involved in other aspects of SUD etiology including drug processing and metabolism are also identified. Studies of gene-environment interaction emphasize the importance of environmental context in SUD. Epigenetic studies indicate drug-specific changes in gene expression as well as differences in gene expression related to the use of multiple substances. Further, gene expression is expected to differ by stage of SUD such as substance initiation versus chronic substance use. While a substantial literature has developed for alcohol and nicotine use disorders, there is comparatively less information for other commonly abused substances. CONCLUSIONS: A better understanding of genetically-mediated mechanisms involved in the neurobiology of SUD provides increased opportunity to develop behavioral and biologically based treatment and prevention of SUD.
No figures extracted from this document.
No entities extracted from this document yet.
No uploaded files.
No papers in this knowledge base cite this source.
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Heterogeneous associations of polygenic indices of 35 traits with mortality: a register-linked population-based follow-up study. | Lahtinen H et al. | β | 2026 | β |
| Parental death and parental substance use problems during childhood and the risk of DSM-5 substance use, suicidality and mental health disorders. | Giang CW et al. | β | 2026 | β |
| Sex Differences in Genetic and Environmental Influences on Age at Initiation of Gaming. | Kim Y et al. | β | 2026 | β |
| Sex Differences in Genetic and Environmental Influences on Age at Initiation of Gaming. | Kim Y et al. | β | 2026 | β |
| The future of addiction psychiatry. | Arruda FS et al. | β | 2026 | β |
| Transcription factors implicated in substance use disorder, from immediate early genes to altered gene expression. | Orr E et al. | β | 2026 | β |
| A Comparative Analysis of Genetic and Epigenetic Factors in METH Addiction: A Focus on <i>SLC</i> (<i>SLC6A4</i>) and <i>COMT</i> Genes. | Hussain HK et al. | β | 2025 | β |
| Addiction Susceptibility: Genetic Factors, Personality Traits, and Epigenetic Interactions with the Gut Microbiome. | Borrego-Ruiz A et al. | β | 2025 | β |
| Assessing the association between ADH5 and ALDH1A1 genetic variants and substance use disorder risk in a Jordanian male population. | Al-Eitan L et al. | β | 2025 | β |
| Association between risk propensity and substance use: A multilevel meta-analysis. | Wang CW et al. | β | 2025 | β |
| Health effects associated with exposure of children to physical violence, psychological violence and neglect: a Burden of Proof study. | Flor LS et al. | β | 2025 | β |
| Heroin Addiction is Associated With Cognitive Deficiency, Neurobiological Alterations and Socio-Demographic Factors in Adolescents. | Tanveer Z et al. | β | 2025 | β |
| Heterogenous associations of polygenic indices of 35 traits with mortality | Lahtinen H et al. | β | 2025 | β |
| Management of alcohol withdrawal syndromes in general hospital settings. | Kast KA et al. | β | 2025 | β |
| The BioSUD Biobank as a genomic resource for substance use disorders in Italy. | Ribatti RM et al. | β | 2025 | β |
| The familial aggregation and co-aggregation of drug use disorder and alcohol use disorder in siblings of affected individuals born 1950-1990: A birth cohort exposed to rising rates of drug use disorder. | Kendler KS et al. | β | 2025 | β |
| What does a dollar mean to you? utilizing intrinsic rewards within contingency management. | Shirazi A et al. | β | 2025 | β |
| Circadian rhythmicity in schizophrenia male patients with and without substance use disorder comorbidity. | Adan A et al. | β | 2024 | β |
| Comprehensive Analysis of the Gene Expression Profiles of Rat Brain Tissues under Environmental Exposure to Nicotine. | Liu W et al. | β | 2024 | β |
| Disentangling heterogeneity in substance use disorder: Insights from genome-wide polygenic scores. | Vilar-RibΓ³ L et al. | β | 2024 | β |
| Explaining the causes and motivations for multiple substance use from the perspectives of users and therapists: A qualitative study. | Mokhtarpoor H et al. | β | 2024 | β |
| Genetic factors linked to aberrant neural activity of individuals with substance use disorder phenotypes: A systematic review and meta-analysis of EEG studies. | Cavicchioli M et al. | β | 2024 | β |
| Interactions Between Genetic, Prenatal Substance Use, Puberty, and Parenting are Less Important for Understanding Adolescents' Internalizing, Externalizing, and Substance Use than Developmental Cascades in Multifactorial Models. | Marceau K et al. | β | 2024 | β |
| Investigating CHRNA5, CHRNA3, and CHRNB4 variants in the genetic landscape of substance use disorder in Jordan. | Al-Eitan L et al. | β | 2024 | β |
| Substance Use Disorder. | Swimmer KR et al. | β | 2024 | β |
| The MIT SUD Ventures Program: Entrepreneurship Training for Researchers in STEM and Beyond. | Salazar-GΓ³mez AF et al. | β | 2024 | β |
| Addressing Substance Use Disorders: Implications for Nursing and for Health Care Systems. | Stone L | β | 2023 | β |
| An approach for prioritizing candidate genes from RNA-seq using preclinical cocaine self-administration datasets as a test case. | Vannan A et al. | β | 2023 | β |
| Examining common and distinct contributions to the etiology of suicide attempt and reattempt. | Lannoy S et al. | β | 2023 | β |
| Examining interactions between polygenic scores and interpersonal trauma exposure on alcohol consumption and use disorder in an ancestrally diverse college cohort. | Sheerin CM et al. | β | 2023 | β |
| Factors related to the development of executive functions: A cumulative dopamine genetic score and environmental factors predict performance of kindergarten children in a go/nogo task. | Fiedler M et al. | β | 2023 | β |
| Modulation of Gut Microbiome in Ecstasy/MDMA-Induced Behavioral and Biochemical Impairment in Rats and Potential of Post-Treatment with <i>Anacyclus pyrethrum</i> L. Aqueous Extract to Mitigate Adverse Effects. | Baslam A et al. | β | 2023 | β |
| Substance Use Disorders in Women. | Polak K et al. | β | 2023 | β |
| Thiol disulfide homeostasis in psychiatric disorders: A comprehensive review. | Ergin Tuncay M et al. | β | 2023 | β |
| Towards a New Dynamic Interaction Model of Adolescent CUD Manifestation, Prevention, and Treatment: A Narrative Review. | Oosten W et al. | β | 2023 | β |
| ADHD co-morbidities: A review of implication of gene Γ environment effects with dopamine-related genes. | Kanarik M et al. | β | 2022 | β |
| A review of mathematical modeling of addiction regarding both (neuro-) psychological processes and the social contagion perspectives. | van den Ende MWJ et al. | β | 2022 | β |
| Association of Polymorphism within the Putative miRNA Target Site in the 3'UTR Region of the <i>DRD2</i> Gene with Neuroticism in Patients with Substance Use Disorder. | BoroΕ A et al. | β | 2022 | β |
| Behavioral phenotypes revealed during reversal learning are linked with novel genetic loci in diversity outbred mice. | Bagley JR et al. | β | 2022 | β |
| Child Maltreatment and Substance Use: A Behavior Genetic Analysis. | Azimi AM et al. | β | 2022 | β |
| Examining protective factors for substance use problems and self-harm behavior during adolescence: A longitudinal co-twin control study. | O'Reilly L et al. | β | 2022 | β |
| Familial co-aggregation and shared heritability between depression, anxiety, obesity and substance use. | Wang R et al. | β | 2022 | β |
| <i>Ankk1</i> Loss of Function Disrupts Dopaminergic Pathways in Zebrafish. | Leggieri A et al. | β | 2022 | β |
| Interactions between Genetic, Prenatal, Cortisol, and Parenting Influences on Adolescent Substance Use and Frequency: A TRAILS Study. | Marceau K et al. | β | 2022 | β |
| Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update. | Fischer B et al. | β | 2022 | β |
| Methylation quantitative locus rs3758653 in the DRD4 gene is associated with duration from first heroin exposure to addiction. | Zhang R et al. | β | 2022 | β |
| Midazolam, methamphetamine, morphine and nicotine intake in high-drinking-in-the-dark mice. | Savarese AM et al. | β | 2022 | β |
| Opioid Use Disorder: Treatment Outcomes in U.S. Veterans. | Griffith PS et al. | β | 2022 | β |
| Pharmacogenetics of Addiction Therapy. | Graham DP et al. | β | 2022 | β |
| Signal in the noise:Β Altered brain activation among adolescent alcohol users detected via the analysis of intra-individual variability<sup>1</sup>. | Bauer LO et al. | β | 2022 | β |
| Substance Use among Youth in Community and Residential Mental Health Care Facilities in Ontario, Canada. | Aderibigbe OO et al. | β | 2022 | β |
| Substance use and substance use disorders in Africa: An epidemiological approach to the review of existing literature. | Onaolapo OJ et al. | β | 2022 | β |
| Association of the Uncoupling Protein 2-866 G/A Polymorphism with Family History and Duration of Tobacco Use Disorder in a Turkish Population. | Mervan Aytac H et al. | β | 2021 | β |
| Drinking and smoking polygenic risk is associated with childhood and early-adulthood psychiatric and behavioral traits independently of substance use and psychiatric genetic risk. | De Angelis F et al. | β | 2021 | β |
| Effect of Auricularia auricula fermentation broth on the liver and stomach of mice with acute alcoholism. | Yu X et al. | β | 2021 | β |
| Genetic basis of cannabis use: a systematic review. | Hillmer A et al. | β | 2021 | β |
| Genetics of substance use disorders: a review. | Deak JD et al. | β | 2021 | β |
| Genomic and Personalized Medicine Approaches for Substance Use Disorders (SUDs) Looking at Genome-Wide Association Studies. | Cozzoli D et al. | β | 2021 | β |
| "If You Could Wave a Magic Wand": Treatment Barriers in the Rural Midwest. | Clark A et al. | β | 2021 | β |
| Molecular genetics of substance use disorders: An umbrella review. | Lopez-Leon S et al. | β | 2021 | β |
| Optical Coherence Tomography findings in patients with Multiple Substance Use Disorder. | Kulu M et al. | β | 2021 | β |
| Pharmacokinetic and pharmacodynamic analyses of cocaine and its metabolites in behaviorally divergent inbred mouse strains. | Zhu J et al. | β | 2021 | β |
| Social Learning and Addiction. | Smith MA | β | 2021 | β |
| Social vulnerabilities for substance use: Stressors, socially toxic environments, and discrimination and racism. | Amaro H et al. | β | 2021 | β |
| The Etiologic, Theory-Based, Ontogenetic Hierarchical Framework of Alcohol Use Disorder: A Translational Systematic Review of Reviews. | Boness CL et al. | β | 2021 | β |
| The Gut Microbiome and Substance Use Disorder. | Russell JT et al. | β | 2021 | β |
| The three-spot seahorse-derived peptide PAGPRGPA attenuates ethanol-induced oxidative stress in LO2 cells through MAPKs, the Keap1/Nrf2 signalling pathway and amino acid metabolism. | Shi J et al. | β | 2021 | β |
| Validity and utility of Hierarchical Taxonomy of Psychopathology (HiTOP): II. Externalizing superspectrum. | Krueger RF et al. | β | 2021 | β |
| Bacchus Listed for a Liver Transplant: Comment. | Robertson AC | β | 2020 | β |
| Investigating the genetic and causal relationship between initiation or use of alcohol, caffeine, cannabis and nicotine. | Chang LH et al. | β | 2020 | β |
| Temperament and Character Profile and Its Clinical Correlates in Male Patients with Dual Schizophrenia. | RΓo-MartΓnez L et al. | β | 2020 | β |
| The Influence of Co-Occurring Substance Use on the Effectiveness of Opiate Treatment Programs According to Intervention Type. | Blondino CT et al. | β | 2020 | β |
| ADGRL3 (LPHN3) variants predict substance use disorder. | Arcos-Burgos M et al. | β | 2019 | β |
| Assessment and Management of Endocarditis Among People Who Inject Drugs in the General Hospital Setting. | Suzuki J | β | 2019 | β |
| Association between polygenic risk for tobacco or alcohol consumption and liability to licit and illicit substance use in young Australian adults. | Chang LH et al. | β | 2019 | β |
| Association between prodynorphin gene polymorphisms and opioid dependence susceptibility: a meta-analysis. | Wang CW et al. | β | 2019 | β |
| Associations between polygenic risk for tobacco and alcohol use and liability to tobacco and alcohol use, and psychiatric disorders in an independent sample of 13,999 Australian adults. | Chang LH et al. | β | 2019 | β |
| Associations of <i>BRAP</i> polymorphisms with the risk of alcohol dependence and scores on the Alcohol Use Disorders Identification Test. | Kim JW et al. | β | 2019 | β |
| Changes in Alcohol Use after Metabolic and Bariatric Surgery: Predictors and Mechanisms. | Ivezaj V et al. | β | 2019 | β |
| Does binge drinking between the age of 18 and 25 years predict alcohol dependence in adulthood? A retrospective case-control study in France. | Tavolacci MP et al. | β | 2019 | β |
| Gene-Environment Interactions in Psychiatry: Recent Evidence and Clinical Implications. | Musci RJ et al. | β | 2019 | β |
| Neural correlates of instrumental responding in the context of alcohol-related cues index disorder severity and relapse risk. | Schad DJ et al. | β | 2019 | β |
| Neurocognitive Precursors of Substance Misuse Corresponding to Risk, Resistance, and Resilience Pathways: Implications for Prevention Science. | Rose EJ et al. | β | 2019 | β |
| Statistical Methods and Software for Substance Use and Dependence Genetic Research. | Lan T et al. | β | 2019 | β |
| Nrf2 in alcoholic liver disease. | Sun J et al. | β | 2018 | β |
| NRF2 mitigates acute alcohol-induced hepatic and pancreatic injury in mice. | Sun J et al. | β | 2018 | β |